Get started
ACADIA PHARMACEUTICALS INC COM STK USD0.0001ACADIA PHARMACEUTICALS INC COM STK USD0.0001ACADIA PHARMACEUTICALS INC COM STK USD0.0001

ACADIA PHARMACEUTICALS INC COM STK USD0.0001

No trades
See on Supercharts
Overview
Financials News Ideas Discussions Technicals Forecast Seasonals

0A4W chart


Full chart

0A4W upcoming earnings

Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪2.94 B‬ USD
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
22.665
Basic EPS (TTM)
0.775 USD
Net income (FY)
‪−61.29 M‬ USD
Revenue (FY)
‪726.44 M‬ USD
Shares float
‪165.12 M‬
Beta (1Y)
1.32

Employees


Employees (FY)
598
Change (1Y)
+85 +16.57%
Revenue / Employee (1Y)
‪1.21 M‬ USD
Net income / Employee (1Y)
‪−102.48 K‬ USD

About ACADIA Pharmaceuticals Inc.


Sector
Health Technology
CEO
Catherine E. Owen
Headquarters
San Diego
Website
acadia.com
Founded
1993
FIGI
BBG00XCCRSH8
ACADIA Pharmaceuticals, Inc. engages in the development and commercialization of medicines for central nervous system disorders. Its products include Nuplazid, which is used for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. The company was founded by Mark R. Brann on July 16, 1993 and is headquartered in San Diego, CA.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—
‪0.00‬

0A4W news



Ideas



See all ideas 

Technicals

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of 0A4W is 18.015 USD — it has increased by 5.93% in the past 24 hours. Watch ACADIA PHARMACEUTICALS INC COM STK USD0.0001 stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on LSE exchange ACADIA PHARMACEUTICALS INC COM STK USD0.0001 stocks are traded under the ticker 0A4W.
0A4W stock has risen by 25.92% compared to the previous week, the month change is a 27.66% rise, over the last year ACADIA PHARMACEUTICALS INC COM STK USD0.0001 has showed a −18.21% decrease.
We've gathered analysts' opinions on ACADIA PHARMACEUTICALS INC COM STK USD0.0001 future price: according to them, 0A4W price has a max estimate of 39.00 USD and a min estimate of 11.00 USD. Watch 0A4W chart and read a more detailed ACADIA PHARMACEUTICALS INC COM STK USD0.0001 stock forecast: see what analysts think of ACADIA PHARMACEUTICALS INC COM STK USD0.0001 and suggest that you do with its stocks.
0A4W reached its all-time high on Jan 4, 2021 with the price of 54.100 USD, and its all-time low was 12.270 USD and was reached on Jun 21, 2022. View more price dynamics on 0A4W chart.
See other stocks reaching their highest and lowest prices.
0A4W stock is 3.38% volatile and has beta coefficient of 1.32. Track ACADIA PHARMACEUTICALS INC COM STK USD0.0001 stock price on the chart and check out the list of the most volatile stocks — is ACADIA PHARMACEUTICALS INC COM STK USD0.0001 there?
Today ACADIA PHARMACEUTICALS INC COM STK USD0.0001 has the market capitalization of ‪3.04 B‬, it has increased by 21.17% over the last week.
Yes, you can track ACADIA PHARMACEUTICALS INC COM STK USD0.0001 financials in yearly and quarterly reports right on TradingView.
ACADIA PHARMACEUTICALS INC COM STK USD0.0001 is going to release the next earnings report on Mar 3, 2025. Keep track of upcoming events with our Earnings Calendar.
0A4W earnings for the last quarter are 0.20 USD per share, whereas the estimation was 0.14 USD resulting in a 44.84% surprise. The estimated earnings for the next quarter are 0.21 USD per share. See more details about ACADIA PHARMACEUTICALS INC COM STK USD0.0001 earnings.
ACADIA PHARMACEUTICALS INC COM STK USD0.0001 revenue for the last quarter amounts to ‪250.40 M‬ USD, despite the estimated figure of ‪248.83 M‬ USD. In the next quarter, revenue is expected to reach ‪276.58 M‬ USD.
0A4W net income for the last quarter is ‪32.77 M‬ USD, while the quarter before that showed ‪33.39 M‬ USD of net income which accounts for −1.87% change. Track more ACADIA PHARMACEUTICALS INC COM STK USD0.0001 financial stats to get the full picture.
No, 0A4W doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Nov 12, 2024, the company has 598.00 employees. See our rating of the largest employees — is ACADIA PHARMACEUTICALS INC COM STK USD0.0001 on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. ACADIA PHARMACEUTICALS INC COM STK USD0.0001 EBITDA is ‪124.54 M‬ USD, and current EBITDA margin is −9.34%. See more stats in ACADIA PHARMACEUTICALS INC COM STK USD0.0001 financial statements.
Like other stocks, 0A4W shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade ACADIA PHARMACEUTICALS INC COM STK USD0.0001 stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So ACADIA PHARMACEUTICALS INC COM STK USD0.0001 technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating ACADIA PHARMACEUTICALS INC COM STK USD0.0001 stock shows the sell signal. See more of ACADIA PHARMACEUTICALS INC COM STK USD0.0001 technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.